Conservative management of cyanoacrylate ankyloblepharon: a case report.
D000368:Aged; D000891:Anti-Infective Agents, Local / Q000627:therapeutic use; D001414:Bacitracin / Q000627:therapeutic use; D003487:Cyanoacrylates / Q000009:adverse effects*; D004338:Drug Combinations / Q000627:therapeutic use; D005141:Eyelid Diseases / Q000139:chemically induced / Q000188:drug therapy / Q000628:therapy*; D006801:Humans; D008297:Male; D009355:Neomycin / Q000627:therapeutic use; D011112:Polymyxin B / Q000627:therapeutic use
D000891:Anti-Infective Agents, Local; D003487:Cyanoacrylates; D004338:Drug Combinations; D001414:Bacitracin; C001816:bacitracin zinc, neomycin sulfate, polymyxin B, drug combination; D009355:Neomycin; D011112:Polymyxin B